PARAGON 28 INC (FNA) Stock Fundamental Analysis

NYSE:FNA • US69913P1057

13.09 USD
0 (0%)
At close: Apr 17, 2025
13.11 USD
+0.02 (+0.15%)
After Hours: 4/17/2025, 8:20:50 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Taking everything into account, FNA scores 3 out of 10 in our fundamental rating. FNA was compared to 185 industry peers in the Health Care Equipment & Supplies industry. FNA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FNA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • FNA had negative earnings in the past year.
  • FNA had a negative operating cash flow in the past year.
  • In the past 5 years FNA reported 4 times negative net income.
  • FNA had negative operating cash flow in 4 of the past 5 years.
FNA Yearly Net Income VS EBIT VS OCF VS FCFFNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

  • FNA's Return On Assets of -18.79% is in line compared to the rest of the industry. FNA outperforms 52.36% of its industry peers.
  • FNA has a Return On Equity (-41.84%) which is in line with its industry peers.
Industry RankSector Rank
ROA -18.79%
ROE -41.84%
ROIC N/A
ROA(3y)-19.77%
ROA(5y)-12.48%
ROE(3y)-38.84%
ROE(5y)-23.97%
ROIC(3y)N/A
ROIC(5y)N/A
FNA Yearly ROA, ROE, ROICFNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

  • With an excellent Gross Margin value of 74.75%, FNA belongs to the best of the industry, outperforming 86.91% of the companies in the same industry.
  • In the last couple of years the Gross Margin of FNA has declined.
  • FNA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.62%
GM growth 5Y-1.89%
FNA Yearly Profit, Operating, Gross MarginsFNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • FNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, FNA has more shares outstanding
  • The number of shares outstanding for FNA has been increased compared to 5 years ago.
  • FNA has a worse debt/assets ratio than last year.
FNA Yearly Shares OutstandingFNA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
FNA Yearly Total Debt VS Total AssetsFNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 4.18 indicates that FNA is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 4.18, FNA is doing good in the industry, outperforming 76.44% of the companies in the same industry.
  • FNA has a Debt/Equity ratio of 0.84. This is a neutral value indicating FNA is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.84, FNA is not doing good in the industry: 72.77% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Altman-Z 4.18
ROIC/WACCN/A
WACC9.36%
FNA Yearly LT Debt VS Equity VS FCFFNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

  • FNA has a Current Ratio of 3.51. This indicates that FNA is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.51, FNA is in the better half of the industry, outperforming 60.21% of the companies in the same industry.
  • A Quick Ratio of 1.64 indicates that FNA should not have too much problems paying its short term obligations.
  • The Quick ratio of FNA (1.64) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.51
Quick Ratio 1.64
FNA Yearly Current Assets VS Current LiabilitesFNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • FNA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.53%.
  • The Revenue has grown by 18.39% in the past year. This is quite good.
  • The Revenue has been growing by 19.23% on average over the past years. This is quite good.
EPS 1Y (TTM)-10.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.48%
Revenue 1Y (TTM)18.39%
Revenue growth 3Y20.2%
Revenue growth 5Y19.23%
Sales Q2Q%18.47%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.91% on average over the next years. This is quite good.
  • FNA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.63% yearly.
EPS Next Y25.22%
EPS Next 2Y21.57%
EPS Next 3Y6.22%
EPS Next 5Y8.91%
Revenue Next Year14.16%
Revenue Next 2Y14.04%
Revenue Next 3Y18.74%
Revenue Next 5Y18.63%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
FNA Yearly Revenue VS EstimatesFNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
FNA Yearly EPS VS EstimatesFNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • FNA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year FNA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FNA Price Earnings VS Forward Price EarningsFNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FNA Per share dataFNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.57%
EPS Next 3Y6.22%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for FNA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

PARAGON 28 INC

NYSE:FNA (4/17/2025, 8:20:50 PM)

After market: 13.11 +0.02 (+0.15%)

13.09

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-06
Earnings (Next)05-08
Inst Owners56.68%
Inst Owner Change-18.48%
Ins Owners15.11%
Ins Owner Change0%
Market Cap1.10B
Revenue(TTM)256.18M
Net Income(TTM)-54.64M
Analysts72
Price Target14.28 (9.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.65%
Min EPS beat(2)-6.82%
Max EPS beat(2)5.52%
EPS beat(4)2
Avg EPS beat(4)-11.35%
Min EPS beat(4)-44.11%
Max EPS beat(4)5.52%
EPS beat(8)3
Avg EPS beat(8)-27.56%
EPS beat(12)3
Avg EPS beat(12)-39.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.09%
Min Revenue beat(2)0.3%
Max Revenue beat(2)1.87%
Revenue beat(4)4
Avg Revenue beat(4)1.03%
Min Revenue beat(4)0.3%
Max Revenue beat(4)1.87%
Revenue beat(8)7
Avg Revenue beat(8)0.91%
Revenue beat(12)11
Avg Revenue beat(12)2.45%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.1%
EPS NY rev (1m)0%
EPS NY rev (3m)1.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.29
P/FCF N/A
P/OCF N/A
P/B 8.41
P/tB 12.96
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS3.05
BVpS1.56
TBVpS1.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -18.79%
ROE -41.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.75%
FCFM N/A
ROA(3y)-19.77%
ROA(5y)-12.48%
ROE(3y)-38.84%
ROE(5y)-23.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.62%
GM growth 5Y-1.89%
F-Score2
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 91.39%
Cap/Sales 6.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.51
Quick Ratio 1.64
Altman-Z 4.18
F-Score2
WACC9.36%
ROIC/WACCN/A
Cap/Depr(3y)195.19%
Cap/Depr(5y)198.62%
Cap/Sales(3y)14.44%
Cap/Sales(5y)13.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.48%
EPS Next Y25.22%
EPS Next 2Y21.57%
EPS Next 3Y6.22%
EPS Next 5Y8.91%
Revenue 1Y (TTM)18.39%
Revenue growth 3Y20.2%
Revenue growth 5Y19.23%
Sales Q2Q%18.47%
Revenue Next Year14.16%
Revenue Next 2Y14.04%
Revenue Next 3Y18.74%
Revenue Next 5Y18.63%
EBIT growth 1Y-9.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year112.67%
EBIT Next 3Y35.33%
EBIT Next 5Y30.86%
FCF growth 1Y52.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.51%
OCF growth 3YN/A
OCF growth 5YN/A

PARAGON 28 INC / FNA FAQ

What is the fundamental rating for FNA stock?

ChartMill assigns a fundamental rating of 3 / 10 to FNA.


What is the valuation status for FNA stock?

ChartMill assigns a valuation rating of 0 / 10 to PARAGON 28 INC (FNA). This can be considered as Overvalued.


What is the profitability of FNA stock?

PARAGON 28 INC (FNA) has a profitability rating of 1 / 10.